Pinnacle Medicines | $89,000,000 | (Mar 27, 2026)
CurrentClient | $1,250,000 | (Mar 27, 2026)
Mirage | $75,000,000 | (Mar 27, 2026)
BRM
United States
- San Francisco, CA
- 06/12/2024
- Series A
- $15,000,000
BRM’s mission is to shift the power from the seller to the buyer. Transform confusing contracts, endless compliance tasks, and runaway spend into an AI-powered source of record. With BRM, you are in control of your entire buying process—from procurement, to compliance, to vendor management.
- Industry Software Development
- Website https://www.brm.ai/
- LinkedIn https://www.linkedin.com/company/brm-labs/
Related People
James McGillicuddyFounder
United States -
Menlo Park, California
I'm Cuddy, CEO and Co-founder of BRM. Our mission is to arm people with the right tools to do their best work. Our buyer-centric tools make buying easier, faster, and more strategic. We level the playing field between buyers and sellers. Ultimately, we are only as good as our tools.
I played football at Stanford. And have taken the learnings of championship teams to help build a winning teams and companies.
When not building BRM, I can be found on the slopes, in a good book, under the water (scuba), or tending my Traegar grill––surrounded by friends and family.
Scalvy | $13,900,000 | (Mar 27, 2026)
SIGMAS | $1,000,000 | (Mar 27, 2026)
VITL | $7,500,000 | (Mar 27, 2026)
Payy | $6,000,000 | (Mar 27, 2026)
Conntour | $7,000,000 | (Mar 27, 2026)
KilgourMD | Undisclosed Amount | (Mar 27, 2026)
Terrestrial | $50,000,000 | (Mar 27, 2026)
Krane | $9,000,000 | (Mar 26, 2026)
Zalos (YC F25) | $3,600,000 | (Mar 26, 2026)